This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Medtronic Ps Medical, Inc.
Medtronic Ps Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development of innovative solutions for patients with chronic conditions. With a focus on neuromodulation and advanced surgical technologies, Medtronic Ps Medical offers a range of core products, including implantable devices and therapeutic systems that enhance patient outcomes. The company operates extensively across North America and has a growing presence in Europe and Asia. Medtronic Ps Medical is recognised for its commitment to research and development, achieving significant milestones in patient care and safety. Its unique approach to integrating cutting-edge technology with patient-centric solutions has solidified its market position, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Medtronic Ps Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic Ps Medical, Inc.'s score of 48 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic Ps Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which may influence its climate commitments and emissions reporting. As part of its corporate family, Medtronic Ps Medical, Inc. inherits climate initiatives and targets from Medtronic plc. However, there are no documented reduction targets or specific climate pledges available for this subsidiary. The absence of emissions data and reduction initiatives suggests that Medtronic Ps Medical, Inc. may still be aligning its strategies with the broader goals set by its parent company. Medtronic plc has been active in addressing climate change, and any commitments or targets from this parent organisation may cascade down to Medtronic Ps Medical, Inc. through their corporate relationship. For detailed information on emissions and climate commitments, stakeholders may need to refer to Medtronic plc's disclosures and sustainability reports.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic Ps Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
